InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
3
T+90 hit rate
12%
T+90 mean return
-15.6%
Across 17 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Lebwohl David, Vice-Président Exécutif et Responsable Médical. Officer active across 1 company, notably Intellia Therapeutics, Inc.. Aggregated, 22 disclosures have been recorded. Split: 0 buy · 3 sells. Total volume traded: €361k. History available since 9 August 2021. The latest transaction was filed on 1 March 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations22 total
43,200 shares0Common StockSEC:0000950170-25-032125:0
9,557 shares@ US$12.1814.3% of flowCommon StockSEC:0000950170-25-003015:0
3,189 sharesCommon StockSEC:0000950170-25-001237:0
38,701 shares0Common StockSEC:0000950170-24-025904:0
5,843 shares@ US$29.4619.9% of flowCommon StockSEC:0000950170-24-002515:0
3,187 sharesCommon StockSEC:0000950170-24-001204:0
30,674 shares0Common StockSEC:0001209191-23-015753:0
2,574 shares@ US$37.2111.5% of flowCommon StockSEC:0001209191-23-002417:0
3,187 sharesCommon StockSEC:0001209191-23-001492:0
3,187 sharesCommon StockSEC:0001209191-22-015960:0
2,400 shares@ US$12.620.0014% mcap6.1% of flowCommon StockSEC:0001209191-21-063698:0
2,400 shares@ US$12.623.3% of flowCommon StockSEC:0001209191-21-063698
2,400 shares@ US$12.620.0014% mcap6.1% of flowCommon StockSEC:0001209191-21-060638:0
2,400 shares@ US$12.623.3% of flowCommon StockSEC:0001209191-21-060638
7,923 shares@ US$12.6210.8% of flowCommon StockSEC:0001209191-21-057778
7,923 shares@ US$12.620.0045% mcap19.8% of flowCommon StockSEC:0001209191-21-057778:0
2,400 shares@ US$12.620.0014% mcap6.0% of flowCommon StockSEC:0001209191-21-057475:0
2,400 shares@ US$12.623.3% of flowCommon StockSEC:0001209191-21-057475
2,400 shares@ US$12.620.0013% mcap6.0% of flowCommon StockSEC:0001209191-21-054317:0
2,400 shares@ US$12.623.2% of flowCommon StockSEC:0001209191-21-054317
2,400 shares@ US$12.620.0014% mcap6.0% of flowCommon StockSEC:0001209191-21-050881:0
2,400 shares@ US$12.623.3% of flowCommon StockSEC:0001209191-21-050881
22 of 22 declarations
About Lebwohl David
Lebwohl David serves as Executive Vice President and Chief Medical Officer at Intellia Therapeutics, Inc. He oversees the company's medical and research strategies, ensuring innovation and advancement of health objectives. His role is crucial in the development of new treatments.
